Pediatric defibrillation doses often fail to terminate prolonged out-of-hospital ventricular fibrillation in children

Marc D Berg1, Ricardo A Samson, Robyn J Meyer

  • 1Sarver Heart Center, University of Arizona College of Medicine, Tucson, AZ 85724, USA. marcb@peds.arizona.edu

Resuscitation
|October 4, 2005
PubMed

Insights

Pediatric defibrillation doses are ineffective for prolonged out-of-hospital cardiac arrest. The standard 2 J/kg dose failed to terminate ventricular fibrillation (VF) in most cases, highlighting a critical knowledge gap.

Area of Science:

  • Pediatric Emergency Medicine
  • Cardiology
  • Resuscitation Science

Background:

  • The current pediatric defibrillation dose (2 J/kg) is based on limited evidence from short-duration ventricular fibrillation (VF).
  • Animal models and a prior pediatric study suggest this dose may be insufficient for prolonged out-of-hospital VF.

Purpose of the Study:

  • To evaluate the effectiveness of the standard pediatric defibrillation dose (2 J/kg) in terminating ventricular fibrillation (VF) during out-of-hospital cardiac arrest.
  • To compare VF termination rates in out-of-hospital pediatric cardiac arrest with historical in-hospital data.

Main Methods:

  • Retrospective analysis of pediatric cardiac arrests (<13 years) in Tucson (1998-2003).
  • Focused on cases with documented ventricular fibrillation (VF) receiving pediatric dose shocks (2 J/kg ±10 J).
  • Compared VF termination rates to a published historical in-hospital pediatric control group.

Main Results:

  • Out of 151 pediatric out-of-hospital cardiac arrests, 13 had VF; 11 received 14 shocks at the standard pediatric dose.
  • Only 7 of 14 shocks (50%) successfully terminated VF, with most leading to asystole or pulseless electrical activity.
  • VF termination failure was significantly higher (7/14) compared to in-hospital data (5/57; OR 10.4, P=0.001).
  • No survivors to hospital discharge were observed in this cohort.

Conclusions:

  • The standard pediatric defibrillation dose is substantially less effective for prolonged out-of-hospital ventricular fibrillation (VF) compared to short-duration in-hospital VF.
  • The optimal defibrillation dose for pediatric out-of-hospital cardiac arrest with prolonged VF remains unknown.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...